TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: Wyngaarden Delays Gene Transfer Study, Seeks all Information; Rosenberg Wins Griffuel Prize October 28, 1988
TCL Archive In Brief: Conference Agrees On $1.664 Billion NCI Budget; NIH Alums Bishop, Varmus Of CSF Win Nobel October 13, 1989
